DIA 2018 Global Annual Meeting

To realize the full potential of RWE, data sources need to be captured longitudinally for individual patients and stored in a centralized database. A shift to the full spectrum and use of RWE sources will result in sophisticated personalized medicine algorithms driven by machine-learning methodologies, targeted drug development and optimized clinical trial recruitment and predictive understanding of disease outcomes and mitigation algorithms.
We will share findings from an ongoing study with the American Migraine Foundation that truly tests the discipline of RWE Science.